RAD 202 receives approval to start Phase 1 therapeutic trial

By December 20, 202428 views

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

House vote imminent on Trump-backed bill to avoid government shutdown

Top 5 NASDAQ Genetics Stocks (Updated January 2025)

Discoveries made by companies in the genetics sector help support every other life science industry ...

17Jan2025

Vanadium Market Forecast: Top Trends for Vanadium in 2025

The vanadium market is poised for shifts this year driven by a projected rise in ...

Enter Your Information Below To Receive Trading Ideas and Latest News

Your name

Your email

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

RAD 202 receives approval to start Phase 1 therapeutic trial

House vote imminent on Trump-backed bill to avoid government shutdown

Malls are using new restaurants to draw consumers as shopping centers reinvent themselves

Popular News

House vote imminent on Trump-backed bill to avoid government shutdown

Malls are using new restaurants to draw consumers as shopping centers reinvent themselves

You may also like

Top 5 NASDAQ Genetics Stocks (Updated January 2025)

Vanadium Market Forecast: Top Trends for Vanadium in 2025

Popular News